March 9, 2020
Teijin’s Alvesco (ciclesonide), an inhaled corticosteroid for asthma treatment, has demonstrated its inhibitory effect against the replication of the novel coronavirus, according to researchers at the National Institute of Infectious Diseases (NIID). Speaking to reporters on March 6, NIID Deputy...read more